CVS Group reported interim results

Diss, Norfolk-headquartered veterinary company CVS Group has reported pre-tax profit of £15.2 million for the first half of its 2026 financial year ending 31 December 2025, down from £15.9 million reported for the first half of its 2025 financial year.

Revenue for the six-month period was £356.9 million, up from £337.3 million reported for the first half of its 2025 financial year.

CVS Group’s chief executive Richard Fairman said: “I am pleased to report that the Group has delivered further solid growth in both revenue and adjusted EBITDA, notwithstanding the softer consumer backdrop in the UK which has impacted footfall in our companion animal practices. CVS has increased its strategic footprint and delivered continued growth in Australia, achieving enhanced returns through synergies and increasing scale benefits.

“Our recent move from AIM to the LSE Main Market marks an exciting milestone for the group and reflects the progress we have made in strengthening our operations. We also look forward to the conclusion of the CMA process in due course.

“With our focus on clinical excellence and investment in practices and people, CVS is well placed to deliver sustainable growth in the medium and longer term.”